Bafilomycin A1

1 MG

Cat. No.: 24-R68

$135.00

Bafilomycin A1 is a macrolide antibiotic that selectively inhibits vacuolar-type (v-type) H+ ATPase. The compound can inhibit E1E2 ATPases from sarcoplasmic reticulum, E. coli, and ox brain versus F1F0 ATPases found in bacteria and mitochondria. It blocks pH regulation in brain cells. Additionally, Bafilomycin A1 prevents lysosomal cholesterol trafficking in macrophages and can be used to distinguish different types of ATPases.

Categories: ,

Details

TECHNICAL INFORMATION

Other Names: (3Z, 5E, 7R, 8S, 9S, 11E, 13E, 15S, 16R)-8-hydroxy-16-[(1S, 2R, 3S)-2-hydroxy-1-methyl-3-[(2R, 4R, 5S, 6R)-tetrahydro-2, 4-dihydroxy-5-methyl-6-(1-methlethyl)-2H-pyran-2-yl]butyl]-3, 15-dimethoxy-5, 7, 9, 11-tetramethyl-oxacyclohexadeca-3, 5, 11, 13-tetraen-2-one

Chemical Formula: C35H58O9

CAS Number: 88899-55-2

Molecular Weight: 622.83

Purity: >98%

IC50= 0.6-1.5nM

Appearance: Crystalline Solid

Solubility: DMSO (100mM)

 

STORAGE AND HANDLING

Storage: Store at 4°C and protected from light. Following reconstitution, store  aliquots at -20°C. 

Stability: Stock solutions stable at -20°C for up to 2 years.

Shipping Conditions: Shipped at room temperature.

 

PRODUCT USE

Soluble in DMSO. Soluble at 20mg/ml

References

Kleinbeck | F. | et al (2012). Total synthesis of bafilomycin A1. Chemistry. 18:3598-610.

Kawaguchi | T. | et al (2011). Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome | autophagy-lysosome and ER stress. Int. J. Oncol. 38:643-54.

Tech Docs

Product Specifications

MSDS

Related products